Leman Micro Devices has developed the only smartphone-integrated solution that measures blood pressure and other vital signs with medical accuracy. The Health Sensor & App is being readied for submission to FDA and other regulators worldwide.
In its CTI Entrepreneurship training programme the CTI offers courses for the business men and women of tomorrow. The programme is divided into four integrated modules. The courses in module 3 and 4 should continue after 2018, but be adapted with a stronger sector-specific focus. Potential service providers can submit their bids until 7 April 2017.
BioMedPartners today announced the first closing of BioMedInvest III, their third equity venture capital fund, at CHF 75 million. The fund will start to invest immediately, and the final closing is foreseen for early 2018.